Patent · US Active

Treatment of NAFLD and NASH

US9381181B2 · kind B2 · utility

29Cited by
16References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2015
Grant dateJul 5, 2016
Priority date—
Expiry dateApr 10, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.